TTM
$6.74B
YoY change
-6.1%
5Y CAGR
-9.9%
Peak year (FY2019)
$12.4B
Cumulative gross profit
$156B
Gross Profit history chart for Biogen (BIIB) from 2016 to 2025
Latest: $6.91B
Gross Profit growth chart for Biogen (BIIB) from 2016 to 2025
Latest: -6.1%
Gross Profit history table for Biogen (BIIB) from 1985 to 2025
| FY2025 | $6.91B | -6.1% | -$452M | ||
| FY2024 | $7.37B | +0.9% | +$63.3M | ||
| FY2023 | $7.3B | -7.5% | -$593M | ||
| FY2022 | $7.9B | -11.0% | -$977M | ||
| FY2021 | $8.87B | -23.8% | -$2.77B | ||
| FY2020 | $11.6B | -6.3% | -$783M | ||
| FY2019 | $12.4B | +6.8% | +$786M | ||
| FY2018 | $11.6B | +9.3% | +$993M | ||
| FY2017 | $10.6B | +6.3% | +$628M | ||
| FY2016 | $10B | +5.2% | +$492M | ||
| FY2015 | $9.52B | +11.6% | +$991M | ||
| FY2014 | $8.53B | +40.5% | +$2.46B | ||
| FY2013 | $6.07B | +22.2% | +$1.11B | ||
| FY2012 | $4.97B | +8.5% | +$388M | ||
| FY2011 | $4.58B | +6.2% | +$266M | ||
| FY2010 | $4.32B | +8.0% | +$321M | ||
| FY2009 | $4B | +8.1% | +$300M | ||
| FY2008 | $3.7B | +30.3% | +$859M | ||
| FY2007 | $2.84B | +17.8% | +$428M | ||
| FY2006 | $2.41B | +79.8% | +$1.07B | ||
| FY2005 | $1.34B | +28.7% | +$299M | ||
| FY2004 | $1.04B | -1156.2% | +$1.14B | ||
| FY2003 | -$98.6M | -124.5% | -$501M | ||
| FY2002 | $403M | -55.5% | -$503M | ||
| FY2001 | $906M | +13.2% | +$105M | ||
| FY2000 | $800M | +17.1% | +$117M | ||
| FY1999 | $683M | +41.5% | +$200M | ||
| FY1998 | $483M | +25.8% | +$99.2M | ||
| FY1997 | $384M | +54.4% | +$135M | ||
| FY1996 | $249M | +76.1% | +$107M | ||
| FY1995 | $141M | -3.6% | -$5.21M | ||
| FY1994 | $146M | +11.8% | +$15.5M | ||
| FY1993 | $131M | +7.7% | +$9.4M | ||
| FY1992 | $122M | +571.3% | +$103M | ||
| FY1991 | $18.1M | +23.1% | +$3.4M | ||
| FY1990 | $14.7M | +345.5% | +$11.4M | ||
| FY1989 | $3.3M | -760.0% | +$3.8M | ||
| FY1988 | -$500K | -96.0% | +$11.9M | ||
| FY1987 | -$12.4M | -26.6% | +$4.5M | ||
| FY1986 | -$16.9M | -259.4% | -$27.5M | ||
| FY1985 | $10.6M | — | — |
- FY2025$6.91B-6.1%
- FY2024$7.37B+0.9%
- FY2023$7.3B-7.5%
- FY2022$7.9B-11.0%
- FY2021$8.87B-23.8%
- FY2020$11.6B-6.3%
- FY2019$12.4B+6.8%
- FY2018$11.6B+9.3%
- FY2017$10.6B+6.3%
- FY2016$10B+5.2%
- FY2015$9.52B+11.6%
- FY2014$8.53B+40.5%
- FY2013$6.07B+22.2%
- FY2012$4.97B+8.5%
- FY2011$4.58B+6.2%
- FY2010$4.32B+8.0%
- FY2009$4B+8.1%
- FY2008$3.7B+30.3%
- FY2007$2.84B+17.8%
- FY2006$2.41B+79.8%
- FY2005$1.34B+28.7%
- FY2004$1.04B-1156.2%
- FY2003-$98.6M-124.5%
- FY2002$403M-55.5%
- FY2001$906M+13.2%
- FY2000$800M+17.1%
- FY1999$683M+41.5%
- FY1998$483M+25.8%
- FY1997$384M+54.4%
- FY1996$249M+76.1%
- FY1995$141M-3.6%
- FY1994$146M+11.8%
- FY1993$131M+7.7%
- FY1992$122M+571.3%
- FY1991$18.1M+23.1%
- FY1990$14.7M+345.5%
- FY1989$3.3M-760.0%
- FY1988-$500K-96.0%
- FY1987-$12.4M-26.6%
- FY1986-$16.9M-259.4%
- FY1985$10.6M—
Gross Profit values are taken from Biogen's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Gross Profit at Biogen (BIIB)
According to Biogen's latest reported financial statements, the company's current gross profit (TTM) is $6.74B. Gross profit equals revenue minus the cost of goods sold (COGS) — what remains from sales after the direct cost of producing the product or service. It does not yet subtract operating expenses, interest, or taxes (see operating income and net income for those steps). Higher gross profit (and gross margin) generally signals pricing power and production efficiency.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of Biogen (BIIB) gross profit is $6.91B – declined 6.1% year-over-year.
Biogen gross profit has contracted on net over the period, with a -9.9% compound annual growth rate over 2020–2025 (5 years).
Biogen gross profit plunged from $12.4B in 2019 to $6.91B in 2025, a 44.3% drawdown.
The highest annual gross profit of $12.4B was reported in 2019. The lowest in the available history was -$98.6M in 2003.
Biogen Gross Profit by Year
Biogen Gross Profit 2025: $6.91B
Biogen posted gross profit of $6.91B in 2025, declined 6.1% below 2024.
Biogen Gross Profit 2024: $7.37B
In 2024, Biogen reported gross profit of $7.37B, edged up 0.9% from 2023.
Biogen Gross Profit 2023: $7.3B
Biogen gross profit in 2023 was $7.3B, declined 7.5% below 2022.
Biogen Gross Profit 2022: $7.9B
2022's gross profit for Biogen came in at $7.9B, declined 11.0% below 2021.
Biogen Gross Profit 2021: $8.87B
Biogen gross profit in 2021 was $8.87B.
See more financial history for Biogen (BIIB).
Sector peers by Gross Profit
Healthcare peers of Biogen (BIIB), ranked by their latest gross profit
| $82.9B | |
| $68.6B | |
| $54.6B | |
| $46.7B | |
| $43B | |
| $39B | |
| $26B | |
| $16.8B |
- $82.9B
- $68.6B
- $54.6B
- $46.7B
- $43B
- $26B
Frequently asked questions
Biogen (BIIB) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
How this company returns cash to shareholders — buybacks, dividends, and stock splits.